EUROAPI EUROAPI

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Cayman Pharma s.r.o.

    Client Virtual Booth

    CAYMAN PHARMA S.R.O

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    • Alprostadil

    • Bimatoprost

    • Cloprostenol Sodium

    • Epoprostenol Sodium

    • Latanoprost

    • Latanoprostene Bunod

    • Tafluprost

    • Travoprost

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cayman VB RM
    Cayman Pharma s.r.o
    CzechRepublic Flag
    Country
    Country
    Czech Republic
    Address
    Address
    Práce 657, 277 11, Neratovice
    Telephone
    Telephone
    +420 313 033 155
    Client Email
    Email
    sales@caymanpharma.cz
    Client Website
    Website
    https://www.caymanpharma.com/home
    Linkedin
    Linkedin
    https://in.linkedin.com/company/cayman-pharma-s-r-o-
    Twitter
    Twitter
    Contact Info
    Others

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration

    Details:

    The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.


    Lead Product(s): KMN-159,Collagen

    Therapeutic Area: Musculoskeletal Product Name: KMN-159

    Highest Development Status: PreclinicalProduct Type: Small molecule

    Partner/Sponsor/Collaborator: NIDCR

    Deal Size: $1.7 million Upfront Cash: Undisclosed

    Deal Type: Funding September 16, 2021

    Cayman Company Banner

    BioFIT 2023

    Not Confirmed

    envelop Contact Supplier
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Cayman Receives SBIR Grant for Alzheimer’s Research

    Details:

    The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.


    Lead Product(s): Antibody

    Therapeutic Area: Neurology Product Name: Undisclosed

    Highest Development Status: PreclinicalProduct Type: Large molecule

    Partner/Sponsor/Collaborator: SBIR

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Funding October 08, 2020

    Cayman Company Banner

    BioFIT 2023

    Not Confirmed

    envelop Contact Supplier
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Cayman VB RM

    BioFIT 2023

    Not Confirmed

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search